January 7, 2019
OncoSec and GOG Foundation join forces to study Tavo in women with cervical cancer
OncoSec Medical Incorporated and GOG Foundation will jointly work to conduct a registration-enabled study of Tavo (tavokinogene telseplasmid) in women with recurrent/persistent cervical cancer (OMS-150), it was announced on Monday.